Abstract
Introduction

49
Parkinson's disease (PD) is a synucleinopathy where degeneration of nigrostriatal dopamine 50 neurons is a core neuropathological feature. It is believed that mitochondrial deficits and aggregation of 51 misfolded α-synuclein (α-syn) are key components of the pathogenic process [1, 2] . Mitochondrial 52 insults, particularly complex I deficiencies, have long been suggested to contribute to the development 53 of PD pathology [3] . Toxins that cause complex I impairment, e.g. 1-methyl-4-phenyl-1,2,3,6-54 tetrahydropyridine (MPTP), have been used to generate animal models of PD, but these typically cause 55 relatively acute degeneration of nigral dopaminergic neurons that is not representative of the 56 progressive pathology of PD. α-Syn pathology has in a few cases been observed in MPTP-treated 57 animals, but they are not a consistent feature of these models [4] . Furthermore, rotenone injections can 58 lead to nigral neuron degeneration, as well as some α-syn pathology, but reproducibility can be 59 problematic due to high rodent mortality [5, 6] .
60
We [7] and others [8, 9] have previously characterized a PD-like neuropathology in the 
125
Brains were then sectioned into 40 m-thick free-floating coronal sections using a freezing microtome.
126
Brain sections were stored in cryoprotectant and quenched with sodium periodate. During the staining 127 protocols, sections were incubated with primary antibodies for tyrosine hydroxylase (mouse anti-TH, 
136
The α-syn inclusions (cell body and neurites) were detected following pS129 staining of a whole series of 137 coronal sections (at 240 m intervals) per animal. The stained slides were blind-coded prior to analysis.
138
We evaluated pS129 inclusions in 8-10 animals per experimental group. Using the 20x magnification on 
160
Densitometric measurements were averaged from a minimum of 2 sections spaced 480 µm apart.
162
Statistics
163
All graphical data are presented as mean ± SEM. Stereological count data were analyzed using negative 164 binomial mixed-effects regression with zero-inflated adjustments in regions with negligible count data.
165
Densitometric measurements were assessed using a linear mixed-effects regression with a random 189 assessed the numbers of α-syn-positive puncta in four regions with direct projections to the striatum -9 the SN, BLA, motor cortex and VTA (Fig. 2, 3) . We used unbiased stereology to count cell bodies
191
immunolabeled with p-S129-α-syn. (Fig. 2A, B) . The numbers of p-S129-α-syn-positive
195
inclusions in the contralateral SN were negligible (Fig. 2B) . We observed no Lewy-like α-syn pathology in
196
any PBS injected control animals. To assess the effects of α-syn pathology on nigrostriatal integrity, we
197 assessed the number of dopaminergic neurons in the SN (TH+) and the optical density of TH+ fibers in 198 the striatum. We observed a significant main effect in the loss of striatal fiber innervation caused by the
199
En1 genotype (p=0.001) as expected, but did not observe any added significant effect due to injection of
200
PFFs (Fig. 2D) . At the level of the substantia nigra, however, the En1 +/-animals (regardless of whether 201 they were injected with PBS or PFFs) did not exhibit significant loss of nigral TH-immunoreactive neurons
202
( Fig. 2C) .
203
In the ipsilateral BLA, there was no significant difference in α-syn pathology between En1-PFF
204
and WT-PFF mice (2202 ± 476 cells and 1046 ± 208 cells, respectively, p = 0.428, Fig. 3A, B) . We noted 205 that the variance was large, and when we analyzed the impact of biological sex we found a marked sex 206 difference, with male En1 +/-mice displaying 359% increase (p=0.007, compared to WT-PFF mice) in 207 pS129+ deposition in the BLA ipsilateral to PFF injection and females exhibiting a non-significant trend
208
for a 14% increase (p=0.350) (Fig. 3B ). In the VTA, similar to the SN, we observed a greater than 3-fold 209 increase in cells with α-syn pathology from the ipsilateral side of En1-PFF mice relative to WT mice (821
210
± 218 cells and 264 ± 34 cells, respectively, p = 0.033), with negligible pathology in the contralateral side 211 (Fig. 3C ). In the motor cortex, we observed no statistically significant difference in α-syn pathology
212
between En1-PFF and WT-PFF mice (Fig. 3D ).
213
To map long distance α-syn pathology propagation in the En1-PFF mice, we used a semi-
214
quantitative scale and determined a mean pathology score based upon p-S129-α-syn-positive perikarya
215
and neurites in all brain regions where α-syn inclusions were detectable. Enhanced pathology (both 216 ipsilateral and contralateral to PFF injection) was observed in En1-PFF mice across a number of cortical 217 regions, as depicted in Figure 4 . The pathology scoring data is summarized in brain-and heat-maps ( Fig.   218 5A, B). While there was less pathology in the olfactory bulb, we observed increased α-syn pathology in 219 the frontal association, orbital, motor, ectorhinal, somatosensory, perirhinal, auditory, and entorhinal 220 cortices of both En1-PFF and WT-PFF mice (Fig. 4) , primarily ipsilateral to the intrastriatal PFF injection,
221
with more pronounced pathology observed in En1-PFF mice (Fig. 4, 5 ).
223 224
Discussion
225
We quantified p-S129-α-syn-positive pathology following injection of α-syn PFFs into the 
247
Although the increase in p-S129-α-syn labeling was most prominent in the SN of the En1 +/-mice, 
256
greater dopamine neuron loss in the nigra compared to VTA in En1 +/-mice [9, 24] . We did not observe 257 reduction in the number of TH-immunoreactive neurons in the SN of En1 +/-mice; however, we detected 258 significant decreases in striatal fiber innervation which are known to precede SN neuron loss both in the
259
En1 heterozygous mouse and in clinical PD [7, 21] . Although SN neuron loss has been previously 12 reported at three months of age [9] , genetic background is known to significantly impact the extent of 
291
Using stereological analysis, we found a non-significant trend for an increase in p-S129-α-syn-
292
positive aggregates in the ipsilateral motor cortex of the En1 +/-mice. Bilaterally, in several other 293 neocortical brain regions which also project to the striatum and where we did not conduct formal
294
quantification of α-syn pathology, the overall visual impression was that there was more p-S129-α-syn 295 staining in the En1 +/-mice (Fig. 4, 5 A, B) . While we did not attempt to quantify pathology in all the 296 cortical regions and cannot judge whether there were robust effects of the absence of one En1 allele, it 297 is possible our study was underpowered to detect differences in α-syn pathology between the En1 +/-and
298
WT mice in the motor cortex. It is also likely that the precise location of the PFF injections in the 299 striatum, which receives topographically region-specific corticostriatal projections, contributed to a high 300 variability that masked a potential effect.
301
Taken together, we suggest that the 
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